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Abstract 
A number of Thrombectomy devices using a variety of methods have now been developed to facilitate clot removal. We 
present research involving one such experimental device recently developed in the UK, called a 'GP' Thrombus-Aspiration-
Device (GPTAD). This device has the potential to bring about the extraction of a thrombus. Although the device is at a 
relatively early stage of development, the results look encouraging. In this work, we present an analysis and modelling of the 
GPTAD by means of the Bond Graph technique; it seems to be a highly effective method of simulating the device under a 
variety of conditions. Such modelling is useful in optimising the GPTAD and predicting the result of clot extraction. The aim 
of this simulation model is to obtain the minimum pressure necessary to extract the clot and to verify that, both the pressure 
and the time required to complete the clot extraction are realistic for use in clinical situations, and are consistent with any 
experimentally obtained data. It is therefore necessary to consider aspects from rheology and mechanics. 
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1. INTRODUCTION 
 Stroke is a major cause of morbidity and mortality 
globally. In the UK alone there are 130.000 strokes each 
year [1]. Even those who survive the initial insult of stroke 
are often left with residual disability resulting in profound 
impact on their life style and life expectancy. 
 Approximately 85% of strokes are caused by a blood 
clot. Intravenous thrombolysis using alteplase is an effective 
treatment for acute stroke [2]. However, there are 
limitations on its use. Due to the risk of haemorrhage it is 
contraindicated in patients who have undergone recent 
surgery. It has to be given relatively early after the stroke 
and it is only licensed for use up to 3 hours post stroke [3], 
although a more recent study has indicated that it could 
possibly be used up to 4 to 5 hours. It can therefore only be 
used in certain patients who have suffered a stroke. 
 
 The need to study new medical devices like the one 
described here means that a computer pre-modelling is 
required in order to proceed to a better optimization and 
fine-tuning of the device. The aim of the simulation model 
that is presented is to obtain the minimum pressure 
necessary to extract the clot and to check that, both this 
pressure and the time required to complete the operation are 
reasonable for potential use in clinical situations, and are in 
line with experimentally obtained data. 
 
2. THROMBOEMBOLIC STROKES 
 Stroke occurs as a result of ischemic or hemorrhagic 
vascular disease. Ischemic stroke has the  potential for 
damage in the penumbral area and in the core, and treatment 
aims  to remove the clot. Methods  have included  surgery, 
clot-dissolving drugs, and  insertion  of thrombus removal 
devices [4]. During the last decade MTDs have become 
more widely used. 
 Major contributing risk factors for stroke include 
dysrthymias e.g. atrial fibrillation; hypertension, cigarette 
smoking and transient ischaemic attacks. A hypertensive 
individual has a four to six fold increased risk of having a 
stroke than a non hypertensive person, and studies have 
shown that antihypertensives can decrease the risk of the 
occurrence of stroke [5].  
 Atherosclerosis is usually caused by excess levels of 
LDL circulating in the body, leading to the formation of an 
atheromatous plaque, which may block the blood vessels 
and may contribute to the formation of blood clots[5]. 
 Smoking increases the risk of atherosclerosis and may 
increase the damage to the endothelial wall of blood vessels 
thus increasing the risk of formation of bloods clots leading 
to an increased risk of stroke. 
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 Smokers have an overall relative risk of 1,5 times that 
of non-smokers [5]; moreover there is a 2,4 greater risk of 
strokes in heavy smokers (20 or more cigarettes a day). 
Excess alcohol consumption may  affect blood clotting and 
blood viscosity, in addition to increasing blood pressure. 
This may in turn give rise to an ischaemic stroke. Other 
causes of stroke include genetic factors e.g. Fabry’s disease 
and CADASIL (Cerebral Autosomal Dominant 
Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy) [6]. Treatments for thromboembolic 
strokes can be divided into three categories: 
 
• Thrombolytic agents; 
• Neuroprotective agents; and 
• Endovascular Thrombectomy (Mechanical devices) 
 
 Thrombectomy devices have been developed as an 
alternative means for clot removal. A number of devices 
using a variety of methods to remove the clot are now 
available. These include the MERCI clot retriever [7], and, 
more recently, the penumbral device [8]. Other types of 
devices include angiography catheters [9] rheolytic catheters 
(Angiojet) [10], Basket style devices [11] and microsnaring 
devices [12]. Thrombectomy has associated risks, such as 
breakage of moving parts, penetration of the arterial wall, 
and downstream embolisation caused by clot dislodgment  
[13, 14]. Studies suggest that mechanical embolectomy is 
most effective in large volume proximal occlusions [15]. 
 Other interventional surgical treatments include 
endarterectomy which involves surgically removing the 
plaque in the carotid arteries. This treatment has proved 
successful [16] but carries a risk of the plaque becoming 
dislodged during the procedure. 
3. ‘GP’ TAD DEVICE 
 The ‘GP’ device (figure 1) [17] is attached to a pump 
that provides the necessary suction pressure for the clot 
removal, joined to a very long catheter; the ‘GP’ TAD is 
located at the end of this catheter. This device is introduced 
into an  artery  in close proximity to  the occluding blood 
clot , and is positioned at a distance of approximately 3 mm 
from it. Then the suction increased until the clot is 
extracted. The clot crosses the 3 mm that separates it from 
the ‘GP’ TAD and clot capture occurs the device is then 
removed from the body. 
 It is currently being developed as a potential thrombus 
aspiration device through a series of in vitro studies. This 
device has the potential to be used in relatively small 
arteries. It has no moving parts and therefore should reduce 
the risk of breakage in a vessel. Since it does not touch the 
clot itself and hence it should also potentially reduce the risk 
of downstream embolisation. Thrombectomy is achieved by 
aspiration through a catheter in which the ‘GP’ device is 
embedded. The internal surface has been  mathematically 
optimized . It is also associated with low forces at the 
periphery of the device which may therefore  reduce the risk 
of arterial collapse during aspiration of the clot [18, 19, 20]. 
The ‘GP’ Aspiration Thrombus Device (TAD) has been 
modelled using a 3-D FLUENT © simulation software 
package [21]. In addition, different existing techniques have 
been considered for the modelling and simulation [22]; 
some methods which have been considered for their 
applicability are the Boltzmann flow simulation technique, 
and finite elements modelling and its implementation in 
Matlab ©, with 2D or 3D models; or by means of Laplace 
transformations using Dynamic Motion Solver © software. 
 
Figure 1. Schematic view of the ‘GP’ Aspiration Thrombus Device 
 
 The objective of this study is to introduce a different 
method to reproduce the model and it can be used in 
showing the potential performance of the ‘GP’ TAD device 
under different conditions of blood flow, size of blood clot, 
in a given vessel. The method chosen for the representation 
and simulation of this model is the Bond Graph technique 
[23]. Some medical models have been modeled by using 
this technique [24, 25] and its choice is based on the fact 
that this technique allows assimilation of the model to an 
electric circuit made up of resistances, capacitances and 
inductances. 
 Therefore, it is possible to obtain the results in a simple 
way by evaluating flows and efforts that join and connect 
the components of the model. 
4. MODELLING THE ‘GP’ ATD DEVICE 
 In this section, we will describe the model used for the 
simulation considering the different phenomena to define 
the device; in addition, the values of the parameters used are 
defined. 
 
4.1. Pump 
 The pump is the component that creates the necessary 
pressure to carry out the extraction. It is represented by a 
variable pressure source (Se=P) whose value will increase 
from zero to 100 kPa, a figure which experience shows to be 
suitable for  carrying out this operation. The time taken to 
reach 100 kPa is 1 sec., after which time the pressure 
provided by the pump remains constant. 
 
4.2. Catheter 
 The catheter is about 1 meter long 1 mm diameter 
hollow cylindrical plastic tube. It is joined to the ‘GP’ 
cylinder of the same diameter and a length of 20 mm. In 
order to represent both elements, they are considered as 
several pipe sections bearing in mind the different 
phenomena that take place in their interior: load (R), the 
inertia loss (I) and the compressibility of the blood (C) [26]. 
 Linear load loss is due to the friction between the liquid 
particles and the pipe walls. Due to their being straight 
pipes, only linear load losses are taken into account. As this 
pipe is horizontal and of constant cross section in each 
section, the load loss is reduced to a pressure loss as the 
fluid advances along the pipe, the loss being progressive and 
proportional to the length of the pipe. It is represented by a 
resistance R, and a type 1 junction.   
 To determine the equation that governs its behaviour, it 
is necessary to know if the behaviour of the blood flow is 
laminar or turbulent. This is evaluated by the Reynolds 
number, giving the following value: 
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 Considering a laminar behaviour, the losses can be 
determined by the following expression:. 
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where η is the dynamic viscosity of the blood flow, L the 
length of the pipe section and D its diameter. In each step of 
the simulation the Reynolds number is checked to be 
according with this criterion. 
 Secondly, the flow inertia to be overcome in its 
movement is taken into account and considering a section 
with circular geometry it can be modelled with this 
expression: 
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where  is the blood density, L the length of the pipe section 
and D its diameter. 
 Lastly, the blood compressibility is included. It acts as a 
spring producing a decrease in volume when the pressure 
required for compression is increased. This behaviour is 
dependent on Bulk's blood coefficient (B) and it is defined 
by a capacitance C with a type 0 junction, by the following 
expression: 
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 In case of use a catheter elastic in the longitudinal 
direction, would be necessary to include the elasticity of the 
material to take into account the length variation; in this 
case we are considering a very rigid catheter in the 
longitudinal direction and it is the reason why we are not 
considering it. 
 In the model to optimize, first the pump is positioned 
then the catheter. Due to its great length it could be 
partitioned in identical sections including the three 
previously described phenomena to study the evolution of 
the pressure loss along the catheter, but due to the linear 
load loss it can be represented only one time. 
  
4.3. GP 
 After the catheter, the ‘GP’ device must be positioned 
and it can be represented by the same three previous 
phenomena and with the corresponding values. In addition, 
due to the artery being located at the end of the ‘GP’ device, 
it is necessary to consider the transition between both 
elements as a pressure loss caused by the difference in 
diameter of the ‘GP’ device and the artery respectively and 
the subsequent variations in flow. 
  
4.4. Deflecting nozzle 
 The load losses commented below can be represented 
as a secondary load loss and it can be represented by a 
resistance considering the difference of both diameters – 
‘GP’ device and artery - with the following expression. 
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where  is the blood density, Q is the flow which circulates 
in the section between the end of the ‘GP’ and the artery, D 
is the mean diameter between the ‘GP’ and the artery, and ξ 
the load loss coefficient. 
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 The load loss coefficient ξ is a dimensionless parameter 
that quantifies the loss produced and depends on the 
geometry of the conical aperture. Considering the results 
obtained in figure 2, the ideal value for the design of the 
‘GP’ device diameter is that which corresponds with the 
same diameter that the artery, in which case it would create 
zero load loss. In patients it is not possible to use the exact 
value and considering it to be a narrowing with DGP = 
1,5·Dartery, this value can be considered as being 0,3 in the 
best case. 
 In eq. (5) the flow which circulates in the section 
between the end of the’GP’ device and the artery is not 
constant during the extraction, so to calculate this 
expression, its value at each instant is considered like the 
flow of the inertance that represent the ‘GP’ device 
(flow(Igp)).   
 
4.5. Artery 
 Such as we commented in section 2, the ‘GP’ device is 
positioned at a distance of approximately 3 mm from the 
occluding blood clot, beginning the suction until the clot 
crosses the distance that separates both and clot capture 
occurs. This space is corresponding with the artery located 
between the end of the ‘GP’ device and the clot and it can 
be deformed as following figure shows due to his elasticity. 
Comparing with the rigid catheter material, in this case we 
need to include this deformation by adding a compliance to 
represent it. 
 
Figure 2. Artery deformation when suction 
 
 This piece of artery can be included in the model as 
another section similar to the catheter or the ‘GP’ device 
and it must be defined by the loss of linear load (R), the 
inertia (I) and the compressibility of the blood (C) in the 
same way the previous phenomena. In addition and 
according with the previous comment, it is necessary to 
insert a parameter that represents the compressibility of the 
artery, in line with its Young‘s modulus:   
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where E is its Young’s modulus, h is the thickness of the 
artery, V0 is the artery initial volume and r0 is the artery 
initial radius. 
4.6. Blood clot 
 Before beginning with the blood clot modeling, it is 
necessary to think that previous elements has been defined 
by using a fluid domain; the blood clot element is 
corresponding with a mass, i.e. a mechanical domain, and it 
is necessary to change from one to the other domain. 
 Then, to be able to evaluate the movements and efforts 
in the clot, as well as to define the physical friction between 
the clot and the artery adding a Transformer (TF) element. 
To calculate the value of the coefficient defining this 
element, the change in the definition of the flow before and 
after this element is evaluated. Before the TF element, the 
flow is in the hydraulics domain, while after, it is in the 
mechanics domain. The coefficient must be determined by 
evaluating the required change between both domains. Since 
the equation that relates both flows is  f2=f1·r, where 
f1=Q1= v1·A1  and  f1=v2, then: 
 
  2
1
11
RArTF      (8) 
 
where R is the artery radius.  
 
 Accurately defining the clot model in order to model it 
is the most complex part of the modelling. In previous 
models [27, 28] the clot has been approximated by the 
authors to a cylindrically-shaped element of [0,5 - 5] cm 
long, and of a mass that falls between [0,5 - 0,1] gram, 
connected to the artery wall by using an equivalent spring-
damper (figs. 3 and 4), with the same adhesion force every 
cases. The model has a spring-damper system in parallel to 
simulate the elastoplastic behaviour of the clot to withstand 
traction. This representation of the internal conditions of the 
clot will be maintained in all subsequent models, although 
they change their name. 
 Additionally, the clot inertia also supports the bond 
strength to the artery. To know when the force will be 
reached in the equivalent spring and, therefore, when the 
clot movement will begin, we calculated the displacement of 
the spring when it is subjected to 0,01 N (and other values 
depending of various parameters) via a typical spring 
equation. Therefore, only when the spring underwent this 
displacement did clot movement begin. No clot movement 
occurred before this value was achieved. This previous 
model has some difficulties that we should redefine. It 
focused on the way we simulated the adhesion of the clot to 
the wall. We think that the simulation of the complete 
catheter was quite realistic, so we kept it, focusing only on a 
new model for studying the clot and its adherence to the 
arterial wall.  
 Consideration of the adhesion force is relatively 
complex, and it is challenging to find the spring-damper rate 
that represents the junction with the wall and we only 
considered the in-vitro maximum adhesion force. The value 
of the constants in both the spring and the damper must be 
extremely high to simulate a firm anchor to the point of 
release. Simulating the moment when the clot breaks loose 
from the wall in the previous model method was very 
difficult, because the junction to the wall had to allow, clot 
movement, according to pressure, even if such pressure was 
not enough to move it in totality. 
 
 
Figure 3. Spring-damper system configuration (F < 0,01 N). 
 
 
 
 
Figure 4. Spring-damper system elimination (F ≥ 0,01 N). 
 
 Due to these problems we look for another solution to 
simulate the clot and its behaviour under pressure. As we 
have seen before, we kept the partitions represented by 
inertia and joined by spring-damper system (Runion, Kunion), 
to simulate the elastic and plastic behaviour of the clot.  
 To model the junction with the artery, the point of 
release and the static and dynamic friction, we decided to 
add to each inertia an effort source that varies depending on 
the moment of the simulation (Effort source F1 to F5 in fig. 
6). Each inertia will suffer a force due to suction, which 
should be compensated in the model with a force of friction 
to annul it, while the clot is in the position of static friction. 
Once we have calculated the flow-effort table of the system, 
we apply the condition that the stress on the inertia must be 
zero. The effort source, as we have said before, varies; i.e. 
when the clot begins its movement, the static friction 
disappears and the dynamic friction acts in the system. It is 
much lower that the static friction. We have calculated it by 
means of the Stokes law for a cylindrical solid: 
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where C is the form coefficient for a cylinder, ρ is the 
blood´s density, D the clot´s diameter and V the velocity of 
the first partition (flow(Mclot1)). 
 The condition to determine if the clot is attached to the 
surface is based on the force that the spring suffers between 
partitions (Kunion). Hence when Kunion·XKunion is higher than 
the adherence force, the clot releases from the surface. The 
value of the adherence force was analyzed by C. J. Flannery 
[29] and we made use of all the necessary data from that. To 
calculate the adhesion strength he consider a not cylindrical 
clot that narrows down the middle due to stenosis or 
atherosclerotic plaque. But this geometry is only valid for 
the condition of static friction, because, once the clot 
releases, it recovers a part of its form and again becomes 
like a cylinder. So, we assume this model and we divided 
this clot into 5 parts: 
 
 
  
Figure 5. Blood clot 5 parts assumption. 
 
 We decided to make these partitions because each one 
has the same contact area with the artery and the same 
volume, in order to simplify the calculation of the adhesion 
force and the mass of each partition. The best option would 
be to recalculate the contact area and volume of each 
partition at every moment when it is moving. 
 As we have defined our clot, we then calculated the 
adhesion force by means of the platelet adhesion force. And 
we have obtained from C.J. Flannery the next equation: 
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where fp is the % of platelets in the clot, SA is the surface in 
contact with the artery and MPA the Mean Platelet Area. 
 Once we have the number of platelets in contact with 
the artery and the force/platelet, we can calculate the 
adhesion force of each partition and obviously of the entire 
clot. In this way we would have different adhesion forces 
depending on the form and size of the clot, and we can 
reference those to the artery diameter and the percentage of 
occlusion. 
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Figure 6. Modelling the full device components and blood clot by Bond Graph technique. 
 
5. RESULTS 
 The fundamental object of this study consists in 
determining and optimizing the minimum pressure required 
for the extraction of a blood clot depending on the clot size. 
To do this, by varying the values of the pressure source and 
clot length, the movement of the clot and the time required 
for its extraction are measured, thereby obtaining the 
optimum minimum pressure. 
 The parameters that define almost completely elastic-
plastic behaviour of the clot and its resistance to breakage 
are the constants Kunion and Runion of the spring-damper 
systems in parallel that are among the partitions of the clot 
and that characterize the clot in the stretch, when it suffers 
the suction before it is detached from the wall.  
 To find the value of the Kunion parameter, Savushkin 
[30] analyzes the stiffness of the clot and the breaking 
strength. We considered that the values are valid, since the 
parameters of the experiments described fall within our 
range, and therefore we can assume that Kunion = 3,41 ± 1,5 
N/m. We took the minimum value 1,91 N/m to study the 
system in the worst possible conditions. We have also find 
in the referred work the rupture force necessary to break the 
clot, so we included it also in our simulation (Frupture = 209 ± 
73 ·10-3 N). 
 Corresponding with the Runion value, Pennati et al. [31]  
described the values for the viscosity of the blood and the 
clot that they use in their model; due to the viscosity of the 
clot; we can assume that Runion = 0,035 kg/m·s. 
 The aim of this simulation is to compare extraction of a 
clot into the Middle Cerebral Artery (2.5 mm) considering 
different clot lengths (1 cm up to 5 cm each case) and 70, 
80, 90 and 100% of occlusion. 
 The size of the artery determines the size of the ‘GP’ 
TAD used to remove the clot. In the study the used size is 1 
mm of diameter for the catheter and the ‘GP’ device. 
 
 To carry out the model validation, the values of the 
parameters used in the simulation are listed in following 
table. 
 
Pressure [0, -100] kPa 
Blood Density () 1060  Kg/m3 
‘GP’ length (L) 0,02 m 
Artery Young modulus (E) 2,8·109 N/m 
Artery thickness (h) 0,1 mm 
Artery length (La) 3 mm 
Artery diameter 2,5 mm 
Blood Viscosity (η) 0,0035 m 
Kunion 1,91 N/m 
Runion 0,035 N·s/m 
Catheter length 1,0 m 
Catheter diameter 1,0 mm 
Clot length [1,0 - 5,0] cm
‘GP’ diameter 1,0 mm 
% of platelets in the clot - fp 0,96  
Mean Platelet Area - MPA 5,31·10-6 mm2 
Fadhesion_platelet 32·10-9 N 
Occlusion [70, 100] % 
 
Table I. Model parameter values. 
 
  The existence of different clot lengths will affect the 
mass of the clot being removed (up to 1 gr.) and increase the 
time taken for clot removal as the value of the clot length 
increases. It has been found, that the greater the rigidity of 
the clot, the shorter the extraction time. This factor is also 
related to the viscosity and composition of the clot that will 
vary in each case. Therefore, for this study we have 
determined the critical values possible, making the 
assumption that there are 96% platelets in the clot, which 
yields a fairly high bond strength, which gives us an idea of 
the maximum pressure needed. 
 Following figure show the movement of each blood clot 
part taking into account the increasing value of the suction 
pressure in the first second according with the comment 
given at section 4.1. Such as it is possible to analyze, one 
time the force over one partition is greater than the adhesion 
force in it between blood clot and artery, the adhesion is 
broken and it begin the movement; additionally, it is 
possible to look that the velocity when one section is 
detached is higher due to all the force is applied over lesser 
partitions. 
 
 
Figure 7. Movement of each blood clot part. 
 
 The breaking strength of the clot, is considered, and is 
taken to an accuracy of an order of magnitude. With this 
data, it is found that in cases Lclot = 5 cm and occlusion 
percentages 80-100%, there is a danger of rupture prior to 
complete clot removal, which would mean the failure of the 
process. Because when the clot breaks up, flow channels 
appear, and the blood begins to circulate through them. 
Consequently it is no longer possible to extract the clot. 
Therefore, it is taken as a benchmark, to call attention to the 
danger of rupture cases. 
 Simulating a range of pressures from 0 to -100 kPa, we 
can observe how it means different times or impossibility to 
proceed with the extraction of the blood clot due to the 
adhesion force. The following figures show the time it takes 
to move the clot 3 mm (first part), which is the distance that 
is maintained during the extraction to the ‘GP’ TAD.  
 Figure 8. Suction pressure Vs required time (100%, 1cm). 
 
 In figure 8 we can observe the different times to extract 
a blood clot in a 100% occlusion case and 1 cm blood clot. 
Although our first study was the obtaining of the minimum 
necessary pressure, we observe clearly the exponential 
tendency and values below 15 kPa for the suction pump 
cannot be used every case due to the increasing required 
time; in this case, the necessary time to detach the first part 
and be possible the extraction pulling the catheter by hand is 
about 5 seconds. 
 Following figures shows the comparison between 70% 
and 100% of occlusion. It is possible to look how the blood 
clot length have a very important influence over the required 
time because it means more inertia due to the mass and 
more contact area, that is, more adhesion force. For 
example, in cases of having a 70% occlusion and 4 cm 
blood clot length we would need 79 secs applying a 
minimum suction pressure of -35 kPa; however, we would 
need only 20 secs applying a suction pressure of -39 kPa. In 
cases where the patient has not time to do it, this pressures 
and times show a very important difference. 
 Figure 9. Result for 70% occlusion and different lengths 
 
 
Figure 10. Result for 100% occlusion and different lengths 
 
 In the case of having a 100% occlusion and 5 cm length 
the blood clot would be broken and some extractions would 
be necessary to do; in the case of 70%, important 
differences exist in the required time if we use -53±1 kPa. 
 Comparing the different occlusion percentages, in the 
figure the lines corresponding with the 70% occlusion are 
always below the ones for 100% occlusion. That is 
reasonable because we have more adherence area for a 
100% occlusion; hence more adherence force and therefore 
we need more time to extract the blood clot. However we 
can observe that for 1 cm length both lines are very similar; 
that is because for such small clots the difference of 
adherence force due to the surface is not so significant as in 
the other cases. 
 On the other hand, studies demonstrate that the artery 
has a resistance of 750 mmHg, which is equivalent to 100 
kPa. This has been analyzed in the model and the pressure 
in this area rises to 4-5 kPa in the worst case, there being a 
wide danger margin for rupture of the artery.  
 
6. CONCLUSIONS  
 For this model we have focused primarily on the 
configuration and simulation of the clot, which was still in 
an early phase of study. We have studied the formation, 
composition and shape of different blood clots in different 
cases, trying to find some general parameters that could 
define their behaviour reliably. In particular we have studied  
the influence of composition, form and some parameters 
that directly affect the adhesive force that holds the clot to 
the arterial wall. 
 But the most significant inclusion in the model, and 
therefore the one that provides greater reliability to the 
model has been the change in the approach regarding the 
internal structure of the clot and its adherence to the wall. 
The clot is broken down into smaller partitions that are 
joined together by a spring-damper system, which 
represents the elastoplastic behaviour of the clot, and whose 
parameters are the stiffness and viscosity 
 To develop the condition of adherence to the wall, 
detachment and subsequent movement of the clot with 
viscous friction, it was decided to approach the action-
reaction, so that the clot would remain at rest by a frictional 
force of equal value, but in the opposite direction, to the one 
associated with each partition until the condition for clot 
movement is fulfilled. For clot movement to occur, the 
frictional force changes to the corresponding value for the 
simulation of dynamic friction. This friction is calculated by 
Stokes law, and considers the motion of a solid cylinder 
within a viscous fluid. 
 With this approach, conditions and parameters, we can 
obtain a fairly accurate simulation of the behaviour of a 
blood clot attached to an artery wall. This is evidenced by 
various simulations and we can demonstrate how each 
partition is involved in the model.  
 The influence of the composition, stiffness, viscosity 
and geometry of the clot on the clot extraction time can be 
seen. The effect of increasing the extraction time factors 
such as the percentage of platelets, the viscosity, the length 
and decreasing of the rigidity of the clot can be modelled. 
The results obtained from modelling are consistent with 
those observed in in-vitro measurements.  
 So we considered that the model is valid and can be 
used for different cases now and in the future, as more 
experimental data become available. 
 It is therefore concluded that the model fits in reality 
and can be extrapolated to different models and cases, due 
to the flexibility and approach of the model under various 
conditions. This model may be used more generally as 
opposed to the previous models we developed which could 
only be used in particular conditions. 
 The main objective of the development of this 
simulation model was to obtain the range of pressure 
required to perform the clot extraction and to check that this 
pressure together with the time required to complete the 
operation are reasonable and within acceptable clinical 
boundaries for eventual potential use of the ‘GP’ TAD in a 
clinical setting. We also confirm that the results are similar 
to experimentally obtained data in vitro. These studies allow 
optimization of the device to assist in possible future use of 
this device in patients with thrombosis. 
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